Aims. To evaluate the perioperative complications associated with total en bloc spondylectomy (TES) in patients with spinal tumours, based on the extent and level of tumour resection. Methods. In total, 307 patients who underwent
Aims. The aim of this study was to investigate the incidence and characteristics of instrumentation failure (IF) after total en bloc spondylectomy (TES), and to analyze risk factors for IF. Methods. The medical records from 136 patients (65 male, 71 female) with a mean age of 52.7 years (14 to 80) who underwent
Total en bloc spondylectomy
(TES) is the total resection of a vertebra containing a tumour.
Many authors have investigated patient-reported outcomes after routine
spinal surgery and surgery for tumours in general. However, this
is the first report of patient-reported outcomes, including health-related
quality of life (HRQoL) and satisfaction, after en bloc vertebral
resection for a spinal tumour. Of the 54 patients who underwent
The main form of treatment of a chordoma of the
mobile spine is total en bloc spondylectomy
(TES), but the clinical results are not satisfactory. Stand-alone
carbon ion radiotherapy (CIRT) for bone and soft-tissue sarcomas
has recently been reported to have a high rate of local control
with a low rate of local recurrence. . We report two patients who underwent
Patients with differentiated thyroid carcinomas (DTCs) have a favourable long-term survival. Spinal metastases (SMs) cause a decline in performance status (PS), directly affecting mortality and indirectly preventing the use of systemic therapies. Metastasectomy is indicated, if feasible, as it yields the best local tumour control. Our study aimed to examine the long-term clinical outcomes of metastasectomy for SMs of thyroid carcinomas. We collected data on 22 patients with DTC (16 follicular and six papillary carcinomas) and one patient with medullary carcinoma who underwent complete surgical resection of SMs at our institution between July 1992 and July 2017, with a minimum postoperative follow-up of five years. The cancer-specific survival (CSS) from the first spinal metastasectomy to death or the last follow-up was determined using Kaplan-Meier analysis. Potential factors associated with survival were evaluated using the log-rank test. We analyzed the clinical parameters and outcome data, including pre- and postoperative disability (Eastern Cooperative Oncology Group PS 3), lung and non-spinal bone metastases, and history of radioiodine and kinase inhibitor therapies.Aims
Methods